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ABSTRACT 
Objective: Studies of composition, stability and antioxidant properties of the betulin-3, 28-diphosphate complexes with dopamine and trisamine.  
Methods: The betulin-3, 28-diphosphate (BDP) interaction with amines in a water-alcohol medium was studied by using spectral methods and 
potentiometric titration. Biochemical indexes such as catalase, superoxide dismutase (SOD), lactate dehydrogenase (LDH) activities and 
malondialdehyde (MDA) level were estimated in experiments on rats.  
Results: BDP was synthesized using betulin by POCl3 treatment in the presence of pyridine in dioxane. The complexation of BDP with amines was 
confirmed by the 31P-NMR and FTIR-spectral data. The stoichiometry of BDP-dopamine complexes was equal to 2:1 and 4:1 and its complexes with 
trisamine were produced in the ratio 1:1 in a water-alcohol medium. The conditional stability constant К′st of the BDP-trisamine complex is 
1130±55 mol∙l-1. BDP-Tris complex improved SOD activity up to 30% and up to 105% in the presence of cytostatic-hydrazine sulfate. The MDA level 
in erythrocytes decreased up to 57% and in combination with cytostatics (5-fluorouracil and hydrazine sulfate)-up to 11-14%. The catalase activity 
increased by 44-94% and MDA level in erythrocytes decreased by 22-53% under the action BDP-DA complexes that depends on the dose.  
Conclusion: The BDP forms stable complexes with trisamine and dopamine that make it possible to use this compound as a component of drug 
delivery system for high toxicity cytostatics and for readily oxidized catecholamines. It has been shown that both its complexes with amines and the 
combination with cytostatics enhanced antioxidant activity in an experiment in vitro. 
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Organic phosphates and phosphonates, which are capable to play a 
role of pro-drugs, are of interest for pharmaceutical and medicinal 
specialists [1]. Besides these compounds as salts significantly 
improve solubility and accordingly drug availability in the human 
body. For example, dexamethasone sodium phosphate in contrast to 
the parent molecule is very soluble in water and demonstrates the 
wide spectrum of the effect in injection form [2]. 
Recently natural bioactive substances modified by phosphate and 
phosphonate groups as potential drugs are intensively studied 
[1,3,4]. Betulin phosphonates as products of betulin modification 
extracted from birch bake showed high efficacy in the treatment of 
breast tumor (duct carcinoma) and brain (glioblastoma), melanoma 
and others in experiments in vitro [5]. 
Antimicrobial, antifungal, anti-inflammatory and antiviral activities 
of BDP were also demonstrated in experiments in vitro and in vivo 
[6-8]. Kaplun A. P. and others showed the ability of BDP to be as an 
inhibitor of complement being a regulating factor of general 
systemic diseases [9]. 
The important advantages of phosphate-containing molecules are 
high ability to interact with amines, amino acids, amino-and NH-
groups of proteins [10] that by Cotton F. A. is a crucial property in 
life processes [11]. The nature of the interaction of phosphate with 
nitrogen-containing fragments is various and includes both covalent 
and hydrogen bonds as well salt formation as complexation due to 
non-specific non-covalent binding [12]. 
It will be expected that formation of the BDP salt complexes with 
amines improves its bioavailability. On the other hand, BDP may be a 
drug delivery agent of readily oxidizable amines such as 
catecholamines binding them in complexes by that to prevent 
amines oxidation. However, data on the betulin phosphate salt 
complexes with organic amines are lacking. 
Trisamine (tris-oxomethyl-aminomethane) (Tris) may be as a 
component of the BDP salt complexes having two acid groups (fig. 1). 
Moreover, Tris has the ability to correct acidosis and ensure plasma 
iso-osmolality [13]. Tris is also used as an active pharmaceutical 
ingredient for bioavailability improving lipophilic drugs. 
 
 
Fig. 1: Betulin-3, 28-diphosphate, dopamine hydrochloride and 
trisamine structures 
 
In this paper we have studied the composition, stability and 
antioxidant properties of the BDP complexes with Tris and readily 
oxidizable catecholamines–dopamine hydrochloride (DA). 
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MATERIALS AND METHODS 
Ethanol 95%, trisamine (“Sigma Aldrich”, 154565-100 G), dopamine 
hydrochloride (“Sigma Aldrich”, LRAA7131), LiClO4, purified water 
(resistivity ≥18 MΩ·cm, “Millipore”). Betulin was isolated from 
Betula Pendula bark by the methods [14]. 
Synthesis of betulin-3,28-diphosphate (BDP) 
6.0 g (13.56 mmol) of betulin was solved in the mixture of 120 
ml of dioxane and 7.08 ml of pyridine (81.6 mmol) in a three-
neck flask at room temperature. 7.56 ml of POCl3 (81.6 mmol) in 
60 ml of dioxane was added to betulin solution dropwise into the 
flask at control temperature (up to 25 °C) then the reaction 
mixture was stirred during 24 h. 1000 g of water mixture and ice 
was added to the reaction mixture and then the white precipitate 
was filtered and washed several times by water. A wet sediment 
containing 25% of water was isolated that corresponds to 
betulin-3,28-diphosphate hydrate (betulin-3,28-diphosphate · 
xH2O, where x=8-9). IR-spectrum (KBr, cm-1): 3421 brd. (ν ОН), 
1641 wk. (ν P=О, ν С=С), 1240 brd. (δ P=О), 1031 brd., 973 brd. 
(ν С-О), 501 nw. (ν P-О). The BDP 13С-NMR spectrum (TMS, 
DMSO-d6, δ, ppm): 
  
№ δ,  
ppm 
№ δ,  
ppm 
№ δ, ppm № δ, ppm № δ,  
ppm 
№ δ, ppm 
С1 38.71 С2 28.27 С3 83.32 С4 38.93 С5 55.25 С6 18.36 
С7 36.93 С8 40.84 С9 50.04 С10 37.42 С11 20.77 С12 25.18 
С13 37.10 С14 42.66 С15 26.92 С16 29.31 С17 47.11 С18 47.62 
С19 48.46 С20 150.31 С21 29.46 С22 34.13 С23 28.53 С24 16.06 
С25 15.27 С26 16.51 С27 14.92 С28 63.60 С29 110.28 С30 19.19 
 The BDP 1Н-NMR spectrum (TMS, DMSO-d6, δ, ppm): 0.68-1.99 (42Н, 6СН3, (СН2)n. m.), 2.35 (1Н at С19, two t.), 3.70 (1Н at С3, =СНОР, two t.), 3.95 
and 3.52 (2Н at С28, СН2OР, two d.), 4.55, 4.68 (2Н at С29, СН2=С, 2s.), 5.72 (protons in phosphate groups О-Р(ОН)2, broad diffuses.).  
 
UV-spectra were recorded by «UV-1800» (Shimadzu, Japan). IR-
spectra were recorded on «IR Prestige-21» (Shimadzu, Japan) in the 
range of 4000-500 cm-1 (tabl. KBr). RP-HPLC-analysis were carried 
out on «LC-20Avp» (Shimadzu, Japan) with UV-detection, the column 
is Discovery C18 (25 cm x 4.6 mm, 5 μm, Supelco), retention time τ 
equal to 5.19 min. 13С, 1H, 31Р–NMR spectra were recorded by using 
NMR-spectrometer «JNM-ECX400» (Jeol, Japan), DMSO-d6, CDCl3, 
D2O; 101, 400 and 202.46 MHz, respectively. 
Biological activity 
Biological activity in vitro was studied by using blood stabilized with 
sodium citrate (1:9). Antioxidant properties were estimated using 
the MDA level in plasma and erythrocytes by the method of M. 
Uchiyama, M. Mihara [15], using catalase and SOD (EC 1.11.1.6, 
1.15.1.1) activities. The energy metabolism in erythrocytes was 
studied using the catalytic activity of LDH (EC 1.1.1.27) in the direct 
(substrate-50 mmol sodium lactate) and reverse (substrate-23 
mmol sodium pyruvate) reactions [16, 17]. 
RESULTS AND DISCUSSION 
Consecutive ionization stages of phosphoric residues of BDP lead to 
the splitting of two protons per phosphate group while the main 
process proceeds in the first stage (fig. 2). 
 
 
Fig. 2: The scheme of betulin-3, 28-diphosphate ionization in 
water-alcohol medium 
 
The amphoteric ion B can be considered both acid and conjugated 
base to this acid. This ion can give a proton away in the aqueous 
solution as an acid or to accept one as a base. Acid-base properties of 
BDP were demonstrated by comparison with its UV-spectra in 
alcohol, water-alcohol, alcohol solution of H2SO4, in aqueous 
solutions of NaOH and in BDP solutions at constant ionic strength 
produced by 1·10-2 M LiClO4 (fig. 3, table 1). 
Table 1: The influence of medium type on the BDP UV-spectra 
Conditions С∙104, M A ε, l∙mol-1∙ cm-1 
95% ethanol 9.8 0.430 439 
95% ethanol, LiClO4 9.8 0.410 418 
4∙10-3M water solution NaOH 9.8 0.410 418 
95% ethanol–water (1:1) 4.9 0.294 588 
95% ethanol–water (1:1), LiClO4 4.9 0.373 761 
0.02M ethanol solution H2SO4 9.8 0.650 663 
 
 
Fig. 3: UV-spectra of 1·10-3M BDP solutions: 1–in 95% alcohol; 2–in 
4∙10-3M NaOH aqueous solution; 3–in 0.02M H2SO4 alcohol solution 
The UV-spectrum of 9.8·10-4M BDP alkaline aqueous solution 
practically identifies to the one in 95% alcohol. The absorbance A 
(n → p* transfer) of BDP in 0.02M H2SO4 solution at λmax=256 nm was 
increased twice in comparison with A in the alcohol solution at the 
same BDP concentration. Similar increase An in UV-spectra in 
alcohol-water solution 1:1 was observed. 
These indicate that BDP is mainly represented by base B both in 
95% alcohol and NaOH aqueous solution but non-ionized BDP is the 
dominant form in the alcohol solution of H2SO4 or water-alcohol 
medium (1:1). The BDP molar extinction coefficient ε is almost half 
as much than for its ionized form. The interaction of DA with BDP 
was studied both in the alcohol medium in which BDP mainly exists 
as an amphoteric base B and in the aqueous solution when BDP may 
be a more acidic or basic compound depending on the reaction 
conditions.  
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The potentiometric titration curve of 8∙10-5M DA solution in water 
by 1∙10-3M BDP alcohol solution shows pH changes of DA solution 
from pH 5.4 (without BDP) to 3.6 after BDP addition (fig. 4, curve 1). 
The data were compared with the blank experiment in water 
solutions containing the same BDP concentration (fig. 4, curve 2).  
 
 
Fig. 4: The dependence of pH on molar ratio αBDP = nBDP/nDA pH = 
f (αBDP) in the BDP-DA system, CDA(initial)= const = 5.0∙10-5M, 
CBDPTitrant = 2.0∙10-3M 
This result may be explained by the formation of BDP-anions with 
the following proton generation in the aqueous medium of DA and 
BDP-anions interaction with a protonated amine (fig. 5). 
 
 
Fig. 5: The interaction of BDP-dianion with protonated amines 
*Cat means catechol fragment 
 
Therefore, BDP as a weak acid or an amphoteric base B and DA as a 
weak base or an acid conjugated with DA are able to form the salts in 
water. However, it should be expected that the salt formation 
according to the scheme (fig. 5) is impossible in the neutral medium 
or in the buffer solution at pH near 7. For this purpose, the 
interaction of BDP with DA has studied in 95% ethanol as a neutral 
medium and in the phosphate buffer at pH 6.86 also. The processes 
were controlled by DA absorption band at 279 nm and by BDP 
absorption band at 256 nm.  
It has been shown that absorption A256 depended on DA molar ratio 
α  

 (fig. 6). At the first stage, A256 has increased by half like in 
0.02M H2SO4 alcohol solution (section I) that characterizes the 
interaction of BDP-anion (base B) with protonated NH3+-group of DA 
and the salt complexes formation. 
 
 
Fig. 6: UV-spectra of BDP-DA alcohol solutions at different molar ratio αDA = nDA/nBDP, CBDP = const = 8.4∙10-4M; the insert shows the 
dependence A256 = f (αDA) 
 
The decreasing of А256 to equilibrium value А256 close to the value А256 
in the initial solution was observed (section II) and then A256 was 
changed insignificantly by the αDA increase when α>1 (section III). The 
А256 maximum and molar extinction coefficient ε (table 2) correspond 
to the stoichiometry of the salt complex with the ratio of BDP to DA 2:1 
and αDA=0.5 if the interaction proceeds in the alcohol solution. 
 
Table 2: The data of UV-spectra to fig. 6 
№ of curves α= 	

	
 A256* ε, l∙mol-1∙ cm-1 
1 0 0.332 395 
2 0.25 0.421 501 
3 0.5 0.505 601 
4 0.75 0.438 521 
5 1 0.380 452 
*A256 was estimated with the amendments of DA absorption 
 
Spectrophotometric titration of 5.0∙10-5M DA solution in phosphate 
buffer at pH 6.86 by 2.0∙10-3 M BDP alcohol solution was stepwise (fig. 7). 
Two discontinuities in curve were observed at αBDP equaled to 2 and 4, 
respectively. The dependence ∆A/∆V = f (VBDP) supported two stages 
process of this interaction that can be considered as complexes 
formation of BDP and DA with stoichiometry 2:1 and 4:1 accordingly. 
Fig. 8 shows the probable structures of complex BDP and DA as the 
complex inclusion. 
Melnikova et al. 




Fig. 7: The dependence of A279 on molar ratio αBDP = nBDP/nDA in the BDP-DA system, CDA (initial)= const = 5.0∙10-5M, phosphate buffer, 
CBDPTitrant = 2.0∙10-3M; insert shows the dependence ∆A/∆V = f (VBDP) 
 
 
Fig. 8: Geometric visualization of BDP as a component of inclusion complexes formed by two and four molecules. Quantum-chemical 
calculations were provided by HyperChem 8.0 (semiempirical method AM1) [18] 
 
The equilibrium in the first stage shifts toward base B when Tris 
aqueous solution was added to 9.8·10-4 M BDP alcohol solution at pH 
2.5. So it may be proposed the absorption A will decrease. The data 
of fig. 9 and table 3 show the decrease of absorption A when molar 
ratio Tris: BDP   

 was increasing. 
 
 
Fig. 9: UV-spectra of BDP and Tris mixtures at constant concentration CBDP=4.9·10-4M, CLiClO4=1·10-2M: a) А = f(λ); b) dependence of 
absorption A on molar ratio А = f(α) or on Tris concentration А=f(СTris) 
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Table 3: The data of UV-spectra to fig. 9 
Curve № α = nTris/nBDP CTris,  
∙104M 
λ, nm А Curve № α = nTris/nBDP CTris,  
∙104M 
λ, nm А 
1 0 0 255.6 0.373 9 1.0 5 259.1 0.286 
2 0.2 1.0 255.7 0.350 10 1.2 6 259.2 0.263 
3 0.3 1.5 255.9 0.341 11 1.4 7 259.5 0.225 
4 0.4 2.0 256.0 0.332 12 1.6 8 260.0 0.194 
5 0.5 2.5 256.6 0.326 13 2.0 10 260.0 0.192 
6 0.6 3.0 256.9 0.317 14 3.0 15 260.0 0.190 
7 0.7 3.5 257.4 0.312 15 4.0 20 260.0 0.190 
8 0.8 4.0 258.9 0.299 16 5.0 25 260.0 0.187 
 
To establish Tris and BDP salt complex stoichiometry spectrophotometric titration was performed in accordance with Job’s method (fig. 10). 
 
 
Fig. 10: Spectrophotometric titration in accordance to the Job’s method. Concentration of initial solutions of BDP and Tris equal to 9.8·10-4M, 
LiClO4 concentration is 1·10-2M, water-alcohol medium: a)А = f(xTris); b) ∆А = f(xTris) 
 
Dependence ∆А = f(xTris) shows that the BDP-Tris complex 
stoichiometry is 1:1 that corresponds to the ratio α  nTris
nBDP
 which 
equales to 1 on section I of dependence А= f(α). Section III may be 
considered as «saturation» of BDP as an acid by Tris as a base in 
accordance with the molar-ratio method that was achieved at α close 
to 1.5. 
Salt character of the complex was confirmed by potentiometric 
titration of BDP alcohol solution by 0.5M Tris aqueous solution and 
comparison of the results with BDP titration by 0.2M NaOH aqueous 
solution (fig. 11). BDP titration curve pH=f(V) has the typical form of 
acid-base titration in both cases but BDP is titrated as a monobasic 
acid in case of Tris and dibasic one by NaOH titration. 
  
 
Fig. 11: Results of potentiometric titration of 10 ml 0.05M betulin-3,28-diphosphate alcohol solution by base aqueous solutions: a) 0.5M 
trisamine; b) 0.2M NaOH 
 
Formation of the BDP salt complexes with the amines was also 
studied using 31Р-NMR-spectra (fig. 12). The chemical shift of 
phosphate at C-3 of BDP equal to -0.58 ppm (doublet without 
decoupling from protons) varied in complex with DA (1:1) to +0.04 
ppm but the chemical shift of phosphorus at C -28 equal to +0.28 
ppm (triplet without decoupling from proton)- up to +0.94 ppm. 
Changes in the spectra insignificantly depend on the ratio of BDP: DA 
with increasing amine fraction (table 4). 
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Fig. 12: 31Р-NMR-spectra of BDP and its complexes: a) with dopamine; b) with trisamine (DMSO-d6, standard Ph3P, δ=5.97±0.03 ppm) 
 
Table 4: The 31P-NMR-spectra data of BDP and its complexes with amines 


















C-3, t 0.28 0.94 0.79 0.68 2.08 2.06 3.71 
 
The stronger changes in the spectra of BDP and Tris mixtures were 
noted. The phosphorus signal at C-3 in BDP shifted from -0.58 ppm 
up to+1.10 ppm and phosphorus at C-28– from +0.28 ppm up to 
+2.08 ppm. The greatest changes with excess of Tris for BDP 
phosphorus at C-28 (δ=3.71 ppm) were observed. It should be 
noted that in all the cases stronger changes in the spectra occurred 
in phosphorus at C-28 of BDP. The FTIR-spectra data suggested 
BDP-Tris complex formation (fig. 13). 
  
 
Fig. 13: FTIR-spectra of BDP (top), BDP-Tris complex (middle), Tris (bottom) 
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The shape and the position of stretch vibration bands of C-O alcohol 
groups in Tris (ν 1041-1022 cm-1) and C-O ester groups (ν 1031-973 cm-
1) in BDP were changed to a broad band in the region of 1070-970 cm-1. 
The stretch vibrations of P-О (ν 497 cm-1) and P=О (ν 1641 cm-1, δ 1215 
cm-1) of BDP were dramatically changed. The hydrophilic index I = T497-
500/T2948 equal to the ratio of transmission at 497 cm-1 to transmission at 
2948 cm-1 (CH, CH2, CH3 of triterpene skeleton) was changed from 3.0 for 
initial BDP to 1.5-1.7 for BDP salt complex with Tris. 
The 31Р-NMR and IR-spectra data suggest that the interaction of BDP 
with amines is due to not only electrostatic forces leading to the salt 
nature of the complex (potentiometric spectrophotometric titration 
data) but also non-specific non-covalent interactions similar to 
interaction of phosphates as phytic acid with amines. 
Consequently, the interaction of BDP with Tris can be regarded as 
the formation of salt complexes due to various intermolecular bonds. 
This interaction between Tris and BDP at the ratio 1:1 can be 
considered as follows:  
BDP+Tris ⇄ Tris∙BDP  





Where the equilibrium molar concentration of the components and 
the complex are indicated in square brackets.  







if values of current concentration are used instead of activity.  
Complex concentration will be much less than the BDP 
concentration upon substantial constant excess of BDP in the 
experiment by the molar ratio method. The Benesi-Hildebrand 
method can be used to determine conditional stability constant 








Where C °BDP=CBDP that it follows from UV-spectra (table 1). 
Complex concentration can be determined using absorption change 
at λ=256 nm and the extinction coefficient due to the salt complex 
formation in accordance with the Bouguer-Lambert-Beer law. 
Сcomplex = ΔА/ε∙d, where d–cuvette thickness.  
Taking into account equations (4) and (5) the Benesi-Hildebrand 
equation takes the form:  
С










 °  (6), 
Where ∆А = А °BDP–Аcurrent BDP(in over the range α = nTris/nBDP from 
0.1 to 1.0); 
С °BDP–initial BDP concentration equal to 4.9∙10-4М;  
d is equal to 1 cm. 
 
 
Fig. 14: Graphical solution of the equation (6) 
 
The conditional stability constant К′st of the salt complex is 1130±55 
mol∙l-1 that was solved graphically using the dependence of С °BDP/А 
on 1/С °Tris (fig. 14). 
The effective molar absorption coefficient of the salt complex !′ in 
accordance with the equation (6) is 422 l∙mol-1·cm-1 which probably 
corresponds to the difference of the molar absorption coefficients of 
initial BDP and the salt complex. Since the molar ratio of initial BDP 
is 746 l∙mol-1·cm-1 the molar absorption coefficient of the complex is 
probably 324 l∙mol-1·cm-1. This value is close to the calculated 
dependence A=f(α) in the plateau region where A=0,190 (fig. 9b): ! 
is 380 l∙mol-1∙cm-1 at the concentration of initial BDP is 5∙10-4М.  
So BDP may form various complexes with amines both of salt 
character, for example, with Tris and inclusion complexes, for 
example, with DA. In the second case, BDP carries out a role of drug 
delivery for readily oxidized drugs or high-toxicity substances.  
In the present study we have characterized antioxidant activity of 
BDP and its complexes with readily oxidized DA and combination 
BDP-Tris complex with high toxicity cytostatics by biochemical 
indexes such as MDA level, SOD and LDH activities as evaluation 
criterion of energy metabolism. 
It has been shown that the lipoperoxidation intensity (by the level of 
MDA) was reduced by half under the action of BDP-Tris complex as 
compared to the control and increased the SOD activity by 30% (table 5). 
 
Table 5: Biochemical parameters under the influence of 2 μg∙ml-1 0.5% aqueous solution of complex BDP-trisamine and its mixture with 
5-fluorouracil (5-FU) or hydrazine sulfate (HS) 
Parameters Control, % 
BDP-trisamine complex (BDP-trisamine complex)+5-FU (BDP-trisamine complex)+HS 
MDAplasma 98.8 13.0 12.9 
MDAerythrocyte 57.0 14.0 10.7 
SOD 128.4 115.7 204.8 
LDHdirect 99.2 100.4 122.6 
LDHreverse 154.2 105.7 294.8 
 
At the same time, it was found that BDP-Tris complex regulated 
energy metabolism in the cell. LDH activity remained practically 
unchanged in the direct reaction under the action of BDP-Tris 
complex whereas LDH activity in the reverse reaction increased 
by half.  
There was a significant improvement in biochemical indexes in case 
of the combination of the toxic cytostatics such as 5-fluorouracil, 
hydrazine sulfate with BDP-Tris complex at a dose of 2 µg/ml. 
High antioxidant activity that established by the level of MDA in 
erythrocytes and by catalase activity in experiment in vitro for 
the solutions of BDP-amine complexes was demonstrated. 
The effectiveness of the BDP-DA complexes is dose-dependent in 
phosphate buffer pH 6.86 under conditions close to physiological. 
The MDA level was decreased by half at a dose of 5 μg/ml under BDP 
action whereas the BDP-DA complex decreased the MDA level at a 
dose of 2 μg/ml (fig. 15, 16, table 6). 
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Fig. 15: Altering of MDA level and catalase activity by using 2 µg/ml 
DA, BDP and their mixture in phosphate buffer 
 
 
Fig. 16: Altering of catalase activity by using 5 µg/ml DA, BDP 
and their mixture in phosphate buffe
Table 6: Biochemical indexes of DA, BDP and their mixture in phosphate buffer 
Sample Control, % 
MDA level in erythrocyte MDA level in plasma Catalase activity 
Dose, µg/ml 
2 5 10 2 5 10 2 5 10 
DA* 61.8 46.2 82.3 200.0 200.0 169.2 249.8 122.5 129.9 
BDP** 57.6 43.7 82.3 215.4 207.7 169.2 142.8 138.4 129.9 
BDP-DA*** 47.0 67.7 78.6 153.9 176.9 115.4 194.2 189.1 144.4 
*1.6 µg/ml DA; **1.25 µg/ml BDP (рН 6.86, phosphate buffer); *** solution of 1.6 mg DA into 1 ml BDP (molar ratio 4:1) 
 
Along with this, the catalase activity increased under the same 
conditions for the BDP-DA complex at doses of 2 and 5 μg/ml (194 
and 189%, respectively), which is higher than the catalase activity 
for BDP at the same doses (143 and 138%, respectively). 
The effect of 0.125% BDP aqueous solution on erythrocytes led to 
decrease the MDA level only at a dose of 10 μg/ml whereas 
catalase activity doubles at a dose of 5 μg/ml. The antioxidant 
activity of the BDP-DA complex in water was stronger than for 
BDP that appears in the decrease of MDA level in erythrocytes up 
to 79% at a dose of 5 μg/ml and the increase of catalase activity 
for all doses (table 7, fig. 17) 
 
Fig. 17: Altering of MDA level in erythrocyte and catalase 
activity by using 5 µg/ml DA, BDP and their mixture.
 
Table 7: Biochemical indexes of DA, BDP and their mixture in water 
Sample Control, % 
MDA level in erythrocyte MDA level in plasma Catalase activity 
Dose, µg/ml 
2  5  10  2  5  10  2  5  10  
DA 69.7 60.9 79.8 153.8 130.8 161.6 225.5 125.5 162.4 
BDP 79.4 99.2 33.6 161.5 161.6 184.5 140.2 205.9 142.3 
BDP-DA 58.0 21.4 59.7 155.2 192.3 123.1 223.7 204.5 200.5 
 
CONCLUSION 
Thus, in this work we have shown that BDP is capable to form 
various complexes with amines having a high antioxidant activity. It 
is expected that the BDP complexes were developed due to salt 
formation and non-specific non-covalent binding. It has been noted 
that the stoichiometry of BDP complexes with DA was equal to 2:1 
and 4:1 just as the stoichiometry of BDP-Tris complexes was 1:1. 
The BDP and its complexes exhibited a stronger antioxidant effect in 
comparison with the initial BDP both in water and phosphate buffer 
that approved the decrease of MDA level and two-fold increase 
catalase activity at all doses. It should be noted that the studied 
compounds showed a significant prooxidant effect in plasma. 
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